Loading...
XKRX
101140
Market cap78mUSD
Dec 05, Last price  
11,650.00KRW
1D
1.30%
1Q
-6.43%
Jan 2017
468.29%
IPO
270.43%
Name

InBioGen Co Ltd

Chart & Performance

D1W1MN
XKRX:101140 chart
P/E
7.21
P/S
16.52
EPS
1,614.69
Div Yield, %
—
Shrs. gr., 5y
35.21%
Rev. gr., 5y
-6.39%
Revenues
7.04b
+12.82%
20,705,199,00020,385,876,00014,648,503,00011,946,873,96010,168,487,0107,966,361,83011,762,124,2308,864,990,96011,545,262,8807,076,785,7207,566,168,6709,795,202,85010,217,711,61010,480,817,71011,403,730,9206,240,804,6307,041,062,000
Net income
16.12b
-14.50%
-25,709,545,0002,014,888,000-13,887,803,000794,544,310-1,368,782,470-1,380,320,740-1,612,375,920-5,686,229,000-2,255,875,010-1,210,953,1901,664,028,88027,234,116,510-45,077,565,37094,124,949,820-119,687,208,17018,857,054,82016,122,334,000
CFO
-33m
L-96.85%
-23,388,648,000-1,131,879,000198,365,000-5,582,068,110369,980,350-1,132,493,190-695,946,830-10,958,169,950344,746,820-426,438,950-1,698,857,130-3,827,874,860-8,032,820,110-7,069,140,260-11,505,134,460-1,050,687,240-33,131,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

INBIOGEN CO.Ltd manufactures and sells footwear for children, youth, and adults in South Korea and internationally. The company markets its products under the ARTIS, SPECS, WANGJA, NEOSPEC, and CHAMPION brands. The company was formerly known as BTONE CO.,Ltd. INBIOGEN CO.Ltd was founded in 1949 and is based in Pyeongtaek, South Korea.
URL
http://www.inbiogen.co.kr/
IPO date
Apr 02, 2008
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT